Jul 19, 2016 - The following slide deck was published by Tomtom NV in conjunction with their 2016 Q2 earnings call.
Jul 19, 2016 - Tomtom NV (TMOAF): Q2 EPS of €0.10 vs. €0.05 in 2Q15. Revenue of €265M (flat Y/Y) Press Release
Jul 19, 2016 - Novartis beat on earnings in the second quarter of 2016.
Jul 18, 2016 - Three drug stocks including industry bellwether Johnson & Johnson (JNJ) will report results on Jul 19.
Jul 15, 2016 - Novartis AG (NVS) is scheduled to report second-quarter 2016 results on Jul 19.
Jul 15, 2016 - Will Tecfidera scrips and sales recover enough to boost Biogen's (BIIB) performance in the second quarter?
Jul 15, 2016 - J&J (JNJ) has a pretty good track record and could beat estimates in the second quarter given the Zacks Rank #2 and +1.80% ESP.
Jul 14, 2016 - Novartis AG (NVS) announced that the FDA's Arthritis Advisory Committee has recommended an approval of the company's proposed biosimilar of Amgen's (AMGN) blockbuster drug, Enbrel (etanercept).
Jul 14, 2016 - Amgen (AMGN) inked an exclusive agreement with Daiichi Sankyo for the commercialization of nine biosimilars in Japan.
May 05, 2016 - Wright Medical Group NV (NASDAQ:WMGI)Q1 2016 Earnings CallMay 04, 2016 4:30 pm ETExecutivesJulie D. Tracy - Chief Communications Officer & Senior VP, Wright Medical Group, Inc.Robert J. Palmisano - Pr